What is the current valuation of the South America Epilepsy Surgery Market?

The market valuation was 124.0 USD Million in 2024. Read More

What is the projected market size for the South America Epilepsy Surgery Market by 2035?

The projected valuation for 2035 is 220.0 USD Million. Read More

What is the expected CAGR for the South America Epilepsy Surgery Market during the forecast period?

The expected CAGR for the market from 2025 to 2035 is 5.35%. Read More

Which surgical procedure type generated the highest revenue in the South America Epilepsy Surgery Market?

Hemispherectomy generated the highest revenue, with a range of 49.0 to 85.0 USD Million. Read More

What are the key player companies in the South America Epilepsy Surgery Market?

Key players include Medtronic, Boston Scientific, Johnson & Johnson, and Abbott Laboratories. Read More

How does the revenue for Refractory Epilepsy compare to other indications?

Refractory Epilepsy shows a revenue range of 40.0 to 75.0 USD Million, indicating strong market demand. Read More

What is the revenue range for Adult patients in the South America Epilepsy Surgery Market?

The revenue range for Adult patients is projected between 70.0 and 125.0 USD Million. Read More

Which technology segment is expected to perform well in the South America Epilepsy Surgery Market?

Imaging Techniques are expected to perform well, with a revenue range of 35.0 to 65.0 USD Million. Read More

What healthcare setting is anticipated to generate the most revenue in the market?

Hospitals are anticipated to generate the most revenue, with a range of 40.0 to 80.0 USD Million. Read More

What trends are influencing the growth of the South America Epilepsy Surgery Market?

Trends include advancements in neurostimulation devices and an increasing number of specialized epilepsy centers. Read More

South America Epilepsy Surgery Market

ID: MRFR/HC/51354-HCR

200 Pages

Rahul Gotadki

Last Updated: March 28, 2026

South America Epilepsy Surgery Market Research Report By Procedure Type (Respective Surgery, Laser Interstitial Thermal Therapy (LITT)), By End User (Hospitals & Clinics, Specialty Centers) and By Region (Brazil, Mexico, Argentina, Rest of South America) - Growth & Industry Forecast 2025 To 2035

South America Epilepsy Surgery Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Surgical Procedure Type (USD Million)
  1. 4.1.1 Resective Surgery
  2. 4.1.2 Functional Surgery
  3. 4.1.3 Lesionectomy
  4. 4.1.4 Hemispherectomy
2. 4.2 Healthcare, BY Indication (USD Million)
  1. 4.2.1 Focal Epilepsy
  2. 4.2.2 Generalized Epilepsy
  3. 4.2.3 Refractory Epilepsy
  4. 4.2.4 Non-Epileptic Seizures
3. 4.3 Healthcare, BY Patient Age Group (USD Million)
  1. 4.3.1 Pediatric
  2. 4.3.2 Adolescent
  3. 4.3.3 Adult
  4. 4.3.4 Geriatric
4. 4.4 Healthcare, BY Technology (USD Million)
  1. 4.4.1 Neurostimulation Devices
  2. 4.4.2 Surgical Navigation Systems
  3. 4.4.3 Imaging Techniques
  4. 4.4.4 Robotic Surgery
5. 4.5 Healthcare, BY Healthcare Setting (USD Million)
  1. 4.5.1 Hospitals
  2. 4.5.2 Specialized Epilepsy Centers
  3. 4.5.3 Outpatient Clinics
  4. 4.5.4 Research Institutions
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medtronic (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Boston Scientific (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Johnson & Johnson (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Abbott Laboratories (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Stryker (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 NeuroPace (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 LivaNova (GB)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Natus Medical (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Integra LifeSciences (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 SOUTH AMERICA MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE
3. 6.3 SOUTH AMERICA MARKET ANALYSIS BY INDICATION
4. 6.4 SOUTH AMERICA MARKET ANALYSIS BY PATIENT AGE GROUP
5. 6.5 SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY
6. 6.6 SOUTH AMERICA MARKET ANALYSIS BY HEALTHCARE SETTING
7. 6.7 KEY BUYING CRITERIA OF HEALTHCARE
8. 6.8 RESEARCH PROCESS OF MRFR
9. 6.9 DRO ANALYSIS OF HEALTHCARE
10. 6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
11. 6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
12. 6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
13. 6.13 HEALTHCARE, BY SURGICAL PROCEDURE TYPE, 2024 (% SHARE)
14. 6.14 HEALTHCARE, BY SURGICAL PROCEDURE TYPE, 2024 TO 2035 (USD Million)
15. 6.15 HEALTHCARE, BY INDICATION, 2024 (% SHARE)
16. 6.16 HEALTHCARE, BY INDICATION, 2024 TO 2035 (USD Million)
17. 6.17 HEALTHCARE, BY PATIENT AGE GROUP, 2024 (% SHARE)
18. 6.18 HEALTHCARE, BY PATIENT AGE GROUP, 2024 TO 2035 (USD Million)
19. 6.19 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
20. 6.20 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
21. 6.21 HEALTHCARE, BY HEALTHCARE SETTING, 2024 (% SHARE)
22. 6.22 HEALTHCARE, BY HEALTHCARE SETTING, 2024 TO 2035 (USD Million)
23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY SURGICAL PROCEDURE TYPE, 2026-2035 (USD Million)
  2. 7.2.2 BY INDICATION, 2026-2035 (USD Million)
  3. 7.2.3 BY PATIENT AGE GROUP, 2026-2035 (USD Million)
  4. 7.2.4 BY TECHNOLOGY, 2026-2035 (USD Million)
  5. 7.2.5 BY HEALTHCARE SETTING, 2026-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

South America Healthcare Market Segmentation

Healthcare By Surgical Procedure Type (USD Million, 2026-2035)

Resective Surgery
Functional Surgery
Lesionectomy
Hemispherectomy

Healthcare By Indication (USD Million, 2026-2035)

Focal Epilepsy
Generalized Epilepsy
Refractory Epilepsy
Non-Epileptic Seizures

Healthcare By Patient Age Group (USD Million, 2026-2035)

Pediatric
Adolescent
Adult
Geriatric

Healthcare By Technology (USD Million, 2026-2035)

Neurostimulation Devices
Surgical Navigation Systems
Imaging Techniques
Robotic Surgery

Healthcare By Healthcare Setting (USD Million, 2026-2035)

Hospitals
Specialized Epilepsy Centers
Outpatient Clinics
Research Institutions

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”